Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between malnutrition-inflammation score and risk of subsequent self-reported bone fractures in prevalent kidney transplant recipients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Plesiomonas shigelloides septicemia and meningitis in a neonate.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK).

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.

Clinical transplantation·2002
Same author

Steroid-free liver transplantation using rabbit antithymocyte globulin induction: results of a prospective randomized trial.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001
Same author

Steroid-free immunosuppression through thymoglobulin induction in liver transplantation.

Transplantation proceedings·2001

Related Experiment Video

Updated: May 30, 2026

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography
09:23

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

Current advances in liver transplantation.

J D Eason1, D L Rowell

  • 1Ochsner Clinic and Alton Ochsner Medical Foundation.

Ochsner Journal
|August 17, 2011
PubMed
Summary

Liver transplantation is the leading treatment for end-stage liver disease, with advances in antiviral therapies and surgical techniques improving outcomes. Donor pool expansion and refined surgical methods enhance patient survival and reduce complications.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Immunology

Background:

  • Liver transplantation is the primary treatment for end-stage liver disease.
  • Hepatitis C, the leading indication, is now manageable with antiviral agents.
  • Hepatitis B recurrence is reduced with immune globulin and antiviral drugs.

Purpose of the Study:

  • To review recent advances in liver transplantation management.
  • To highlight improvements in treating common indications like hepatitis C and B.
  • To discuss surgical innovations and donor pool expansion strategies.

Main Methods:

  • Review of medical and surgical advancements in liver transplantation.
  • Analysis of outcomes with new antiviral therapies for hepatitis C and B.

More Related Videos

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

Related Experiment Videos

Last Updated: May 30, 2026

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography
09:23

Successful Orthotopic Liver Transplantation in Mice Utilizing Microcomputed Tomography Angiography

Published on: September 22, 2023

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

  • Evaluation of surgical techniques and donor expansion strategies.

    • Main Results:

    • Antiviral therapies improve pre- and post-transplant outcomes for hepatitis C and B.
    • Potent immunosuppressants reduce acute rejection; chronic rejection remains a challenge.
    • Surgical advances like VVB and T-tube elimination decrease morbidity.
    • Donor pool expansion through marginal donors and in-situ splitting increases transplant availability.

    Conclusions:

    • Liver transplantation is a highly effective treatment for end-stage liver disease.
    • Medical and surgical advancements continue to improve patient outcomes and expand eligibility.
    • Addressing chronic rejection and optimizing donor utilization are key future directions.